,palbociclib,sacituzumab govitecan,letrozole,trastuzumab deruxtecan
gilead sciences,daiichi sankyo,pfizer,astrazeneca,roche,novartis
['destiny-breast03', 'paloma-2', 'breast', 'tropics-02']
is there a more stacked lineup than tomorrows breast cancer late breaker session? - destiny-breast03 - tropics-02
- daiichi sankyo s her3 targeted med
- paloma-2 just a few #asco22
Pharmacist • RTP | Neurology ??, Oncology ??, Cardiology ?? | Passionate about improving patient access to medications | #TwitteRx